199 related articles for article (PubMed ID: 1568221)
1. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Olopade OI; Jenkins RB; Ransom DT; Malik K; Pomykala H; Nobori T; Cowan JM; Rowley JD; Diaz MO
Cancer Res; 1992 May; 52(9):2523-9. PubMed ID: 1568221
[TBL] [Abstract][Full Text] [Related]
2. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.
Olopade OI; Buchhagen DL; Malik K; Sherman J; Nobori T; Bader S; Nau MM; Gazdar AF; Minna JD; Diaz MO
Cancer Res; 1993 May; 53(10 Suppl):2410-5. PubMed ID: 7683574
[TBL] [Abstract][Full Text] [Related]
3. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group.
James CD; He J; Collins VP; Allalunis-Turner MJ; Day RS
Cancer Res; 1993 Aug; 53(16):3674-6. PubMed ID: 8339274
[TBL] [Abstract][Full Text] [Related]
4. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.
Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP
Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529
[TBL] [Abstract][Full Text] [Related]
5. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
Chen ZH; Zhang H; Savarese TM
Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
[TBL] [Abstract][Full Text] [Related]
6. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia.
Coleman A; Fountain JW; Nobori T; Olopade OI; Robertson G; Housman DE; Lugo TG
Cancer Res; 1994 Jan; 54(2):344-8. PubMed ID: 8275465
[TBL] [Abstract][Full Text] [Related]
7. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
8. Scaffold-associated regions in the human type I interferon gene cluster on the short arm of chromosome 9.
Strissel PL; Dann HA; Pomykala HM; Diaz MO; Rowley JD; Olopade OI
Genomics; 1998 Jan; 47(2):217-29. PubMed ID: 9479494
[TBL] [Abstract][Full Text] [Related]
9. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
10. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia.
Olopade OI; Bohlander SK; Pomykala H; Maltepe E; Van Melle E; Le Beau MM; Diaz MO
Genomics; 1992 Oct; 14(2):437-43. PubMed ID: 1385305
[TBL] [Abstract][Full Text] [Related]
11. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
Dreyling MH; Bohlander SK; Adeyanju MO; Olopade OI
Cancer Res; 1995 Mar; 55(5):984-8. PubMed ID: 7867008
[TBL] [Abstract][Full Text] [Related]
12. Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer.
Mead LJ; Gillespie MT; Irving LB; Campbell LJ
Cancer Res; 1994 May; 54(9):2307-9. PubMed ID: 8162570
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
14. Deletions of interferon genes in acute lymphoblastic leukemia.
Diaz MO; Rubin CM; Harden A; Ziemin S; Larson RA; Le Beau MM; Rowley JD
N Engl J Med; 1990 Jan; 322(2):77-82. PubMed ID: 2294436
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors.
James CD; He J; Carlbom E; Nordenskjold M; Cavenee WK; Collins VP
Cancer Res; 1991 Mar; 51(6):1684-8. PubMed ID: 1998958
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
18. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
20. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
